| Latest Flamel Technologies S.A. ADS News Headlines | | Date | Time | Source | | | 03/22/2007 | 10:48AM | PRNUS | GSK Announces Nationwide Availability of Once-A-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
PHILADELPHIA, March 22 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) announced today that Coreg CR(TM) (carvedilol phosphate) extended- release capsules, a once-a-day beta-blocker, is now available at pharmacies nationwide. COREG CR is FDA-approved to treat three cardiovascular conditions:
- High blood pressure... More...>> |
| 10/20/2006 | 7:35PM | PRNUS | FDA Approves New, Once-a-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
PHILADELPHIA, Oct. 20 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) and Flamel Technologies (NASDAQ:FLML) today announced FDA approval of once-a-day Coreg CR(TM) (carvedilol phosphate) extended-release capsules, for the treatment of three cardiovascular conditions:
* High blood pressure, also known as hypertension... More...>> |
| 05/17/2006 | 8:30AM | PRNUS | New Data Show COREG CR (TM) Reduced Blood Pressure in Patients With Essential Hypertension Study Presented at American Society for Hypertension Meeting Reports Once-Daily Formulation Well-Tolerated and Provided Continuous 24-hour Blood Pressure Reduction
PHILADELPHIA, May 17 /PRNewswire-FirstCall/ -- Coreg CR(TM) (carvedilol phosphate controlled-release capsules), a controlled-release beta blocker, reduced... More...>> |
| 04/18/2005 | 4:30PM | PRNUS | E*TRADE Financial Announces Stephen H. Willard Joins Board of Directors E*TRADE Financial Announces Stephen H. Willard Joins Board of
Directors
NEW YORK, April 18 /PRNewswire-FirstCall/ -- E*TRADE FINANCIAL Corporation
(NYSE:ET) today announced that Stephen H. Willard, who has been a member of the
Board of Directors of E*TRADE Bank since 2000, has joined the Board of
Directors of E*TRADE... More...>> |
|